Oric Pharmaceuticals, Inc. ORIC Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s retained earnings?
- Oric Pharmaceuticals, Inc. (ORIC) reported retained earnings of -$728.01M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s retained earnings changed year-over-year?
- Oric Pharmaceuticals, Inc.'s retained earnings decreased by 22.8% year-over-year, from -$592.8M to -$728.01M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s retained earnings has grown at a 33.0% compound annual growth rate (CAGR), from -$166.39M to -$692.24M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.